Search

Search Results
Results 17311 - 17320 of 17460 for Depression
  • Genox
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Genox (tamoxifen) intended for persons living in Australia.
  • Diclofenac Sodium Viatris (formerly Fenac)
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Diclofenac Sodium Viatris (formerly Fenac) (diclofenac sodium) intended for persons living in Australia.
  • E-Mycin
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about E-Mycin (erythromycin) intended for persons living in Australia.
  • Cozavan
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Cozavan (losartan potassium) intended for persons living in Australia.
  • Cosamide 50
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Cosamide 50 (bicalutamide) intended for persons living in Australia.
  • Brooke
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brooke (drospirenone 3 mg and ethinylestradiol 20 micrograms) intended for persons living in Australia.
  • Brooklynn
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brooklynn (drospirenone 3 mg and ethinylestradiol 30 micrograms) intended for persons living in Australia.
  • Eating Disorder Symptoms
    Health - 19 Jun 2023
    Symptoms and complications related to the various eating disorders vary according to the severity of the eating disorders.
  • Isoptin
    Drug - 6 Apr 2023
    Consumer Medicine Information (CMI) about Isoptin intended for persons living in Australia.
  • Viramune XR
    Drug - 31 Mar 2023
    Consumer Medicine Information (CMI) about Viramune XR intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback